Literature DB >> 20165692

Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors.

Isabela Werneck Cunha1, Katia Candido Carvalho, Waleska Keller Martins, Sarah Martins Marques, Nair Hideko Muto, Roberto Falzoni, Rafael Malagoli Rocha, Samuel Aguiar, Ana C Q Simoes, Lucas Fahham, Eduardo Jordão Neves, Fernando Augusto Soares, Luiz Fernando Lima Reis.   

Abstract

Soft tissue tumors represent a group of neoplasia with different histologic and biological presentations varying from benign, locally confined to very aggressive and metastatic tumors. The molecular mechanisms responsible for such differences are still unknown. The understanding of these molecular alterations mechanism will be critical to discriminate patients who need systemic treatment from those that can be treated only locally and could also guide the development of new drugs' against this tumors. Using 102 tumor samples representing a large spectrum of these tumors, we performed expression profiling and defined differentially expression genes that are likely to be involved in tumors that are locally aggressive and in tumors with metastatic potential. We described a set of 12 genes (SNRPD3, MEGF9, SPTAN-1, AFAP1L2, ENDOD1, SERPIN5, ZWINTAS, TOP2A, UBE2C, ABCF1, MCM2, and ARL6IP5) showing opposite expression when these two conditions were compared. These genes are mainly related to cell-cell and cell-extracellular matrix interactions and cell proliferation and might represent helpful tools for a more precise classification and diagnosis as well as potential drug targets.

Entities:  

Year:  2010        PMID: 20165692      PMCID: PMC2822450          DOI: 10.1593/tlo.09166

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  52 in total

1.  Functional polymorphisms of JWA gene are associated with risk of bladder cancer.

Authors:  Chun-Ping Li; Yu-Jie Zhu; Rui Chen; Wei Wu; Ai-Ping Li; Jia Liu; Qi-Zhan Liu; Qing-Yi Wei; Zheng-Dong Zhang; Jian-Wei Zhou
Journal:  J Toxicol Environ Health A       Date:  2007-06

2.  Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.

Authors:  Susanne V Allander; Peter B Illei; Yidong Chen; Cristina R Antonescu; Mike Bittner; Marc Ladanyi; Paul S Meltzer
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.

Authors:  Sylvain L'Espérance; Ion Popa; Magdalena Bachvarova; Marie Plante; Nancy Patten; Lin Wu; Bernard Têtu; Dimcho Bachvarov
Journal:  Int J Oncol       Date:  2006-07       Impact factor: 5.650

4.  Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH.

Authors:  Yasuo Takahashi; Yukimoto Ishii; Yayoi Nishida; Masahito Ikarashi; Toshihito Nagata; Takeshi Nakamura; Shunji Yamamori; Satoshi Asai
Journal:  Cancer Genet Cytogenet       Date:  2006-07-01

5.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

6.  Sarcomas often express constitutive nitric oxide synthases (NOS) but infrequently inducible NOS.

Authors:  Isabela W Cunha; Ademar Lopes; Roberto Falzoni; Fernando A Soares
Journal:  Appl Immunohistochem Mol Morphol       Date:  2006-12

7.  Reduced Mcm2 expression results in severe stem/progenitor cell deficiency and cancer.

Authors:  Steven C Pruitt; Kimberly J Bailey; Amy Freeland
Journal:  Stem Cells       Date:  2007-08-23       Impact factor: 6.277

8.  Identification of prognostic biomarkers for prostate cancer.

Authors:  Farhad Kosari; Jan Marie A Munz; C Dilara Savci-Heijink; Craig Spiro; Eric W Klee; Dagmar Marie Kube; Lori Tillmans; Jeff Slezak; R Jeffrey Karnes; John C Cheville; George Vasmatzis
Journal:  Clin Cancer Res       Date:  2008-03-15       Impact factor: 12.531

9.  Classification and subtype prediction of adult soft tissue sarcoma by functional genomics.

Authors:  Neil H Segal; Paul Pavlidis; Cristina R Antonescu; Robert G Maki; William S Noble; Diann DeSantis; James M Woodruff; Jonathan J Lewis; Murray F Brennan; Alan N Houghton; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Identification of JWA as a novel functional gene responsive to environmental oxidative stress induced by benzo[a]pyrene and hydrogen peroxide.

Authors:  Rui Chen; Wen Qiu; Zulong Liu; Xingjiang Cao; Ting Zhu; Aiping Li; Qingyi Wei; Jianwei Zhou
Journal:  Free Radic Biol Med       Date:  2007-02-28       Impact factor: 7.376

View more
  22 in total

1.  XB130, a novel adaptor protein, promotes thyroid tumor growth.

Authors:  Atsushi Shiozaki; Monika Lodyga; Xiao-Hui Bai; Jeya Nadesalingam; Takeshi Oyaizu; Daniel Winer; Sylvia L Asa; Shaf Keshavjee; Mingyao Liu
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.

Authors:  Hongyan Wang; Chunpeng Zhang; Anna Rorick; Dayong Wu; Ming Chiu; Jennifer Thomas-Ahner; Zhong Chen; Hongyan Chen; Steven K Clinton; Kenneth K Chan; Qianben Wang
Journal:  Cancer Res       Date:  2011-05-18       Impact factor: 12.701

Review 3.  Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker.

Authors:  Zhonglin Hao; Hui Zhang; John Cowell
Journal:  Tumour Biol       Date:  2011-12-16

4.  Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.

Authors:  Lucía López-Corral; Luis Antonio Corchete; María Eugenia Sarasquete; María Victoria Mateos; Ramón García-Sanz; Encarna Fermiñán; Juan-José Lahuerta; Joan Bladé; Albert Oriol; Ana Isabel Teruel; María Luz Martino; José Hernández; Jesús María Hernández-Rivas; Francisco Javier Burguillo; Jesús F San Miguel; Norma C Gutiérrez
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

5.  Comparative genomic analyses identify common molecular pathways modulated upon exposure to low doses of arsenic and cadmium.

Authors:  Margaret Ann Benton; Julia E Rager; Lisa Smeester; Rebecca C Fry
Journal:  BMC Genomics       Date:  2011-04-01       Impact factor: 3.969

6.  Roles of XB130, a novel adaptor protein, in cancer.

Authors:  Atsushi Shiozaki; Mingyao Liu
Journal:  J Clin Bioinforma       Date:  2011-03-17

7.  Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1.

Authors:  Inga Hinrichsen; Benjamin Philipp Ernst; Franziska Nuber; Sandra Passmann; Dieter Schäfer; Verena Steinke; Nicolaus Friedrichs; Guido Plotz; Stefan Zeuzem; Angela Brieger
Journal:  Mol Cancer       Date:  2014-01-24       Impact factor: 27.401

8.  Multigenic nature of the mouse pulmonary adenoma progression 1 locus.

Authors:  Alice Dassano; Sara Noci; Federica Galbiati; Francesca Colombo; Gaia Trincucci; Angela Pettinicchio; Tommaso A Dragani; Giacomo Manenti
Journal:  BMC Genomics       Date:  2013-03-06       Impact factor: 3.969

9.  miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

Authors:  Andrea Feliciano; Josep Castellvi; Ana Artero-Castro; Jose A Leal; Cleofé Romagosa; Javier Hernández-Losa; Vicente Peg; Angels Fabra; Francisco Vidal; Hiroshi Kondoh; Santiago Ramón Y Cajal; Matilde E Lleonart
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

10.  Meta-analysis and gene set analysis of archived microarrays suggest implication of the spliceosome in metastatic and hypoxic phenotypes.

Authors:  Bertrand De Meulder; Fabrice Berger; Eric Bareke; Sophie Depiereux; Carine Michiels; Eric Depiereux
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.